We are principally engaged in (i) manufacturing and sales of prescription drugs, including chemical drugs and prescribed traditional Chinese medicines in the PRC; and (ii) operating fitness centres and providing consultation services for fitness and health activities, and operating franchise business for royalty fee income.

We provide medical-related products in accordance with the relevant pharmaceutical regulations and adopted GMP in all of our manufacturing plants.

Our chemical drugs production base located in Beijing and active pharmaceutical ingredients and intermediates active pharmaceutical ingredients production base located in Chongqing City have all obtained the GMP certification from the National Medical Products Administration of China. The active pharmaceutical ingredients and intermediates active pharmaceutical ingredients production line located in Chongqing City holds a valid FDA certification and the Prequalification of the World Health Organisation, while Chongqing Kangle holds a valid new WHO PQ for an active pharmaceutical ingredient. The Active Pharmaceutical Ingredients Chloroquine Phosphate, which was previously recognised by the National Medical Products Administration of China (formerly known as the China Food and Drug Administration), has also been tested and proven to be the treatment and allopathy of pneumonia infected by COVID-19 by the Consumable and Industrial Committee of the Ministry of Industry and Information Technology of the PRC* (中國工業和信息化部消費品工業司), Chongqing Economy and Informatization Commission and the Economy and Informatization Commission of Changshou District of Chongqing City* (重慶市長壽區經濟和信息化委員會).